| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 56.04 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : - |
EPS(TTM) : 50.03 |
|
Book Value(₹) : 269.24 |
Market Cap(₹Cr) : 112,323.63 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,529.74 | 2,403.26 | 1,996.55 | 2,358.57 | 2,260.47 | 2,092.28 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,529.74 | 2,403.26 | 1,996.55 | 2,358.57 | 2,260.47 | 2,092.28 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 137.75 | 124.07 | 107.43 | 67.23 | 84.20 | 86.94 |
| Total Income | 2,667.49 | 2,527.33 | 2,103.98 | 2,425.80 | 2,344.67 | 2,179.22 |
| Total Expenditure | 1,777.71 | 1,831.06 | 1,481.38 | 1,755.46 | 1,662.33 | 1,594.32 |
| PBIDT | 889.78 | 696.27 | 622.60 | 670.34 | 682.34 | 584.90 |
| Interest | 1.92 | 6.26 | 4.03 | 4.26 | 4.31 | 1.97 |
| PBDT | 887.86 | 690.01 | 618.57 | 666.08 | 678.03 | 582.93 |
| Depreciation | 85.42 | 83.40 | 82.25 | 89.73 | 77.01 | 68.51 |
| Tax | 131.23 | 108.34 | 104.53 | 74.41 | 111.84 | 91.36 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 36.78 | -15.22 | -22.38 | 14.87 | 16.30 | 13.78 |
| Reported Profit After Tax | 634.43 | 513.49 | 454.17 | 487.07 | 472.88 | 409.28 |
| Extra-ordinary Items | 31.99 | 29.24 | 23.58 | 0.00 | 26.09 | 29.50 |
| Adjusted Profit After Extra-ordinary item | 602.44 | 484.25 | 430.59 | 487.07 | 446.79 | 379.78 |
| EPS (Unit Curr.) | 15.84 | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 |
| EPS (Adj) (Unit Curr.) | 15.84 | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 |
| Calculated EPS (Unit Curr.) | 15.84 | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 |
| Calculated EPS (Adj) (Unit Curr.) | 15.84 | 12.82 | 11.34 | 12.16 | 11.80 | 10.22 |
| Calculated EPS (Ann.) (Unit Curr.) | 63.35 | 51.27 | 45.35 | 48.64 | 47.22 | 40.87 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 63.35 | 51.27 | 45.35 | 48.64 | 47.22 | 40.87 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 | 40.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.17 | 28.97 | 31.18 | 28.42 | 30.19 | 27.96 |
| PBDTM(%) | 35.10 | 28.71 | 30.98 | 28.24 | 30.00 | 27.86 |
| PATM(%) | 25.08 | 21.37 | 22.75 | 20.65 | 20.92 | 19.56 |